Login / Signup
Sofosbuvir, Glecaprevir, Pibrentasvir, and Ribavirin as a Rescue Therapy in Difficult-to-Treat HCV Patients.
Magdalena Meszaros
Régine Truchi
Denis Ouzan
Albert Tran
Marc Bourlière
Georges-Philippe Pageaux
Published in:
Hepatology (Baltimore, Md.) (2021)
Keyphrases
</>
hepatitis c virus
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
human immunodeficiency virus
patient reported outcomes
stem cells
mesenchymal stem cells
bone marrow
cell therapy
patient reported